Emily Mullin wrote . . . . .
Molecular biologist David Sinclair wants to revolutionize the way people age. Sinclair is 46, but he’s been obsessed with what he calls “the gravity of life” since he was 4 years old.
A professor of genetics at Harvard Medical School and co-director of the university’s Paul F. Glenn Laboratories for the Molecular Biology of Aging, he has founded a slew of startup biotechnology companies with the lofty aim of developing drugs intended to extend the human life span. Specifically, he wants to create a pill that could simultaneously combat Alzheimer’s disease, cancer, diabetes and heart disease to ensure that people live longer, healthier lives.
Sinclair is at the forefront of research investigating a chemical called resveratrol, a compound found in such plants as grapes and cocoa, that works by activating SIRT1, a protein believed to play a role in regulating life span…
View original post 1,081 more words